Arrowhead Pharmaceuticals Inc (ARWR)
Interest coverage
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 83,079 | -75,072 | -89,248 | -600,255 | -580,108 | -525,685 | -455,027 | -282,542 | -188,165 | -168,267 | -142,088 | -150,455 | -174,831 | -155,884 | -115,706 | -188,304 | -149,037 | -134,273 | -118,351 | -112,359 |
| Interest expense (ttm) | US$ in thousands | 89,361 | 82,314 | 63,026 | 48,631 | 32,352 | 22,967 | 23,031 | 20,844 | 18,326 | 14,647 | 10,729 | 6,726 | 5,033 | 9,570 | 9,610 | 10,080 | 11,093 | 9,195,473 | 11,528,843 | 11,529,724 |
| Interest coverage | 0.93 | -0.91 | -1.42 | -12.34 | -17.93 | -22.89 | -19.76 | -13.56 | -10.27 | -11.49 | -13.24 | -22.37 | -34.74 | -16.29 | -12.04 | -18.68 | -13.44 | -0.01 | -0.01 | -0.01 |
September 30, 2025 calculation
Interest coverage = EBIT (ttm) ÷ Interest expense (ttm)
= $83,079K ÷ $89,361K
= 0.93